Incanthera (AQSE:INC) EV-to-EBIT : -9.70 (As of May. 25, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Incanthera EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Incanthera's Enterprise Value is £10.32 Mil. Incanthera's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was £-1.06 Mil. Therefore, Incanthera's EV-to-EBIT for today is -9.70.

The historical rank and industry rank for Incanthera's EV-to-EBIT or its related term are showing as below:

AQSE:INC' s EV-to-EBIT Range Over the Past 10 Years
Min: -11.17 Med: 0 Max: 0
Current: -9.7

AQSE:INC's EV-to-EBIT is ranked worse than
100% of 426 companies
in the Biotechnology industry
Industry Median: 10.295 vs AQSE:INC: -9.70

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Incanthera's Enterprise Value for the quarter that ended in Sep. 2023 was £5.14 Mil. Incanthera's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was £-1.06 Mil. Incanthera's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -20.70%.

Incanthera EV-to-EBIT Historical Data

The historical data trend for Incanthera's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera EV-to-EBIT Chart

Incanthera Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

EV-to-EBIT

-5.47

-8.46

-4.54

-5.35

Incanthera Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EV-to-EBIT	Get a 7-Day Free Trial			-	-4.54	-	-5.35	-

Competitive Comparison of Incanthera's EV-to-EBIT

For the Biotechnology subindustry, Incanthera's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Incanthera's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Incanthera's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Incanthera's EV-to-EBIT falls into.

Incanthera EV-to-EBIT Calculation

Incanthera's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	10.316	/	-1.064
	=	-9.70

Incanthera's current Enterprise Value is £10.32 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Incanthera's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was £-1.06 Mil.

Incanthera (AQSE:INC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Incanthera's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 )	=	EBIT	/	Enterprise Value (Q: Sep. 2023 )
	=	-1.064	/	5.1408367
	=	-20.70 %

Incanthera's Enterprise Value for the quarter that ended in Sep. 2023 was £5.14 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Incanthera's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was £-1.06 Mil.

Incanthera EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Incanthera's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 King Street, Manchester, GBR, M2 4NH

Website

http://www.incanthera.com

Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines